Andrasina et al., 2021 - Google Patents
Thermal ablation and transarterial chemoembolization are characterized by changing dynamics of circulating MicroRNAsAndrasina et al., 2021
- Document ID
- 14852862147974068437
- Author
- Andrasina T
- Juracek J
- Zavadil J
- Cechova B
- Rohan T
- Vesela P
- Paldor M
- Slaby O
- Goldberg S
- Publication year
- Publication venue
- Journal of Vascular and Interventional Radiology
External Links
Snippet
Purpose To determine whether the levels of circulating microRNAs (miRNAs) are altered in patients undergoing thermal ablation and chemoembolization and whether these changes are predictive of a clinical outcome. Material and Methods This prospective study consisted …
- 229920001239 microRNA 0 title abstract description 89
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lan et al. | Serum exosomal lncRNA XIST is a potential non‐invasive biomarker to diagnose recurrence of triple‐negative breast cancer | |
Barfeld et al. | Androgen-regulated metabolism and biosynthesis in prostate cancer | |
Le Calvez-Kelm et al. | KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control | |
Cheng et al. | Circulating miR-106a is a novel prognostic and lymph node metastasis indicator for cholangiocarcinoma | |
Fang et al. | Plasma MicroRNA pair panels as novel biomarkers for detection of early stage breast cancer | |
Soliman et al. | Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer | |
Andrasina et al. | Thermal ablation and transarterial chemoembolization are characterized by changing dynamics of circulating MicroRNAs | |
Brandes et al. | Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET) | |
Dawe et al. | Brain metastases in non–small-cell lung cancer | |
Ganapathy-Kanniappan et al. | Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists | |
Theiss et al. | Gastrointestinal stromal tumors of the stomach and esophagus | |
Zitt et al. | Circulating Cell‐Free DNA in Plasma of Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiation: A Potential Diagnostic Tool for Therapy Monitoring | |
Ali et al. | Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization | |
WO2018204725A1 (en) | Theranostic tools for management of pancreatic cancer and its precursors | |
Maleckaite et al. | DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma | |
Ohaegbulam et al. | The multidisciplinary management of cholangiocarcinoma | |
Bhangu et al. | Circulating cell-free DNA in plasma of colorectal cancer patients-A potential biomarker for tumor burden | |
Liang et al. | CyclinD1 is a new target gene of tumor suppressor miR-520e in breast cancer | |
Liu et al. | Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer | |
Wang et al. | Predictive significance of serum level of vascular endothelial growth factor in gastric cancer patients | |
Masuda et al. | Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations | |
Zhang et al. | Research progress review on long non-coding RNA in colorectal cancer. | |
Hur et al. | Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis | |
Improta et al. | Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity | |
Luo et al. | Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization |